Benchmark Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$270K	Buy	+556	New	+$270K	0.17%	80
2022 Q1	–	Sell	-938	Closed	-$206K	–	160
2021 Q4	$206K	Buy	+938	New	+$206K	0.17%	96